Previous studies indicated that the dysregulation of SERPINA5 has been implicated in migration, invasion and metastasis in hepatocellular carcinoma, ovarian and prostate cancers (Bijsmans et al., 2011; Cao et al., 2003; Jing et al., 2014). This evidence concerns the gene SERPINA5 and hepatocellular carcinoma.